期刊文献+

Ghrelin基因多态性与2型糖尿病的相关性 被引量:7

Association of human ghrelin gene polymorphism with type 2 diabetes mellitus
下载PDF
导出
摘要 目的探讨ghrelin基因多态性与2型糖尿病之间的关系。方法进行ghrelin基因C408A和G346A的多态性分析,同时进行生化指标和临床参数的检测。结果正常对照组(NGT组)C408A基因型CC、CA、AA的基因型频率分别为75.4%、24.0%及0.6%。2型糖尿病组(DM组)中CC、CA及AA的基因型频率分别为70.8%、28.2%及1.0%。NGT组CC基因型者总胆固醇水平明显高于CA+AA基因型者(P<0.05);DM组CC基因型者血尿酸水平明显高于CA+AA基因型者(P<0.05)。在所有的受试者中未发现G346A多态性存在。结论Ghrelin基因C408A分布与等位基因频率没有明显的差异;本组人群中未发现ghrelinG346A多态性存在;C408A多态性与总胆固醇和尿酸水平相关。 Objective To study the relationship between ghrelin gene polymorphisms and type 2 diabetes. Methods All subjects were genotyped for these two single nucleotide polymorphisms (C408A, G346A ) of ghrelin by PCR-RFLP assay. Anthropometric variables, blood glucose, insulin, lipid, uric acid and other clinic parameters were measured. Results In control group, the genotype frequencies are as follows : CC 75.4% ( n = 251 ) , CA 24. 0% (n =80) , and AA 0. 6% (n =2). In type 2 diabetes group, the genotype frequencies are as follows: CC 70. 8% (n = 143) , CA 28.2% (n =57) , and AA 1.0% (n =2). There was no significant differences of the genotype frequencies in two groups. In control group, serum total cholesterol in subjects carrying CC genotype was higher than that of subjects without CC genotype ( P 〈 0. 05 ) ; in type 2 diabetes groups, serum uric acid in subjects carrying CC genotype was higher than that of subjects without CC genotype ( P 〈 0. 05 ). There was no G346A variants existed in our study subjects. Conclusion The allele frequencies and genotype distribution of the C408A was not different between control and type 2 diabetes groups; G346A polymorphism was not found in control and type 2 diabetes groups. C408A variants is related with total cholesterol and uric acid.
出处 《基础医学与临床》 CSCD 北大核心 2008年第1期44-47,共4页 Basic and Clinical Medicine
基金 首都医学发展科研基金(2002-1017)
关键词 GHRELIN基因 多态性 2型糖尿病 总胆固醇 尿酸 ghrelin gene polymorphism type 2 diabetes total cholesterol uric acid
  • 相关文献

参考文献9

  • 1Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growthhormone-releasing acylated peptide from stomach [ J ]. Nature, 1999,402 : 656 - 660.
  • 2Korbonits M, Gueorguiev M, OGrady E, et al. A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children [ J ]. J Clin Endocrinol Metab, 2002, 87:4005 -4008.
  • 3毛微波,郭晓蕙,高妍,童玉,唐朝枢.Ghrelin促进大鼠胰岛素合成及高葡萄糖诱导的胰岛素分泌[J].基础医学与临床,2004,24(4):432-435. 被引量:12
  • 4Katsuki A, Urakawa H, Gabazza EC, et al. Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus[J]. Eur J Endocrinol, 2004, 151 : 573 - 577.
  • 5Ukkola O, Ravussin E, Jacobson P, et al. Role of ghrelin polymorphisms in obesity based on three different studies [J]. Obes Res, 2002, 10:782 -791.
  • 6Kim SY, Jo DS, Hwang PH, et al. Preproghrelin Leu72Met polymorphism is not associated with type 2 diabetes mellitus[J]. Metabolism Clin & Exp, 2006, 55: 366- 370.
  • 7Bing C, Ambye L, Fenger M, et al. large-scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabolic syndrome and associated quantitative traits [J]. Diabet Med, 2005, 22: 1157- 1160.
  • 8Tseng CH. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan [J]. Kidney Int, 2005, 68: 796- 801.
  • 9Langenberg C, Bergstrom J, Laughlin GA, et al. Ghrelin and metabolic syndrome in older adults [ J ]. J Clin endocrinol Metab, 2005, 90. 6448-6453.

二级参考文献10

  • 1Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach[J]. Nature, 1999, 402:656-660.
  • 2Tschop M, Smiley DL, Heiman ML, et al. Ghrelin induces adiposity in rodents[J]. Nature, 2000, 407:908-913.
  • 3Tschop M, Wawarta R, Riepl RL, et al. Post-prandial decrease of circulating human ghrelin levels[J]. J Endocrinol Invest, 2001, 24:RC19-21.
  • 4Tschop M, Weyer C, Tataranni PA, et al. Circulating ghrelin levels are decreased in human obesity[J]. Diabetes, 2001, 50:707-709.
  • 5Man ZW, Zhu M, Noma Y, et al. Impaired (-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM[J]. Diabetes, 1997, 46:1718-1724.
  • 6Papotti M, Ghe C, Cassoni P, et al. Growth hormone secretagogue binding sites in peripheral human tissues[J]. J Clin Endocrinol Metab, 2000, 85:3803-3807.
  • 7Date Y, Murakami N, Kojima M, et al. Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats[J]. Biochem Biophys Res Commun, 2000, 275:477-480.
  • 8Wierup N, Svensson H, Mulder H, et al. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas[J]. Regul Pept, 2002, 107:63-69.
  • 9Date Y, Nakazato M, Hashiguchi S, et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion[J]. Diabetes, 2002, 51:124-129.
  • 10Toshinai K, Mondal MS, Nakazato M , et al. Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration[J]. Biochem Biophys Res Commun, 2001, 281:1220-1225.

共引文献11

同被引文献77

  • 1时春艳,杨慧霞,谢翠英,董悦.妊娠期糖代谢异常对巨大儿发生率及其他相关问题的影响[J].中华围产医学杂志,2005,8(1):9-12. 被引量:90
  • 2周丽萍,王智红,周维,刘晓瑛.妊娠期糖耐量异常对妊娠结局的影响[J].中国妇幼保健,2006,21(23):3227-3229. 被引量:7
  • 3Kojima M,Hosoda H,Date Y,et al.Ghrelin is a growth-hormone-releasing acylated peptide from stomach.Nature,1999,402:656-660.
  • 4van der Lely AJ,Tsch(o)p M,Heimau ML,et al.Biological,physiological,pathophysiological,and pharmacological aspects of ghrelin.Endocr Rev,2004,25:426-457.
  • 5Kola B,Korbollits M.Shedding light on the intricate puzzle of ghrelin's effects on appetite regulation.J Endocrinol,2009,202:1-9.
  • 6Higgins SC,Gueorguiev M,Korbonits M.Ghrelin,the peripheral hunger hormone.Ann Med,2007,39:116-136.
  • 7Berthold HK,Giannakidou E,Krone W,et al.The Leu72Met polymorphism of the ghrelin gene is associated with a decreased risk for type 2 diabetes.Clinica Chimica Acta,2009,399:112-116.
  • 8Ukkola O,Ravussin E,Jacobson P,et al.Mutations in the preproghrelin/ghrelin gene associated with obesity in humans.J Clin Endocrinol Metab,2001,86:3996-3999.
  • 9Poykko S,Ukkola O,Kauma H,et al.Ghrelin Arg51Gln muta tion is a risk factor for type 2 diabetes and hypertension in a random sample of middle-aged subjects.Diabetologia,2003,46:455-458.
  • 10McCowen KC,Maykel JA,Bistrian BR,et al.Circulating ghrelin concentrations are lowered by intravenous glucose or hyperinsulinemic euglycemic conditions in rodents.J Endocrinol.2002,175:R7-11.

引证文献7

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部